
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Lindeman obtained his undergraduate degree in Chemistry at Williams College. He obtained his M.D. at the University of Rochester and trained in anatomic and clinical pathology at the University of California in San Francisco. Neal completed his fellowship in molecular genetic pathology at Brigham and Women's Hospital. Since graduating with fellowship, Dr. Lindeman was an attending pathologist at Brigham and Women's Hospital in clinical chemistry and molecular diagnostics. Neal's research focuses on cancer diagnostics and genomics.
Neal has served in leadership roles in many prestigious pathology societies, including vice chair of the CAP molecular oncology committee. He is also ...
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.
EXaCT-2: an augmented and customizable oncology-focused whole exome sequencing platform.
Factors Influencing Choice of Laboratory-Developed Tests and US Food and Drug Administration (FDA)-Approved or FDA-Cleared In Vitro Diagnostics for Molecular Analytes.